DOI: 10.1097/ms9.0000000000005284 ISSN: 2049-0801

Robot-assisted Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a cohort study of 156 cases

Xiaofeng Duan, Haochen Wang, Yuxuan Zhang, Jie Yue, Chuangui Chen, Zhao Ma, Zuoyu Chen, Chen Zhang, Shangren Wang, Chunyu Hou, Wencheng Zhang, Hongjing Jiang
Show PDF Cite

Background:

To compare the efficacy and safety of neoadjuvant therapy (NT) followed by robot-assisted Ivor-Lewis esophagectomy vs. upfront surgery (S) in patients with locally advanced adenocarcinoma of the esophagogastric junction (AEG).

Methods:

We retrospectively analyzed 156 patients with locally advanced AEG (cT2–4a/N0–2) who underwent robot-assisted Ivor-Lewis surgery with intrathoracic anastomosis between 2017 and 2024. Baseline characteristics, pathological responses, and surgical outcomes were compared between the NT and S groups. Survival data were evaluated using Kaplan–Meier analysis.

Results:

Of the 156 patients, 41 (26.3%) received NT. The NT group achieved a pathological complete response (pCR) rate of 24.4% (vs. 0% in the S group) and higher node-negative rates (pN0: 56.1% vs. 32.2%, P = 0.009), with significant downstaging in pT stage (T0–2: 41.5% vs. 17.4%, P < 0.001), TNM stage (I–II: 53.7% vs. 23.5%, P < 0.001), and lymphovascular invasion (7.3% vs. 27.0%, P = 0.008). Surgical outcomes were comparable between groups, including conversion rates (9.8% vs. 10.4%, P = 1.000), anastomotic leaks (2.4% vs. 4.3%, P = 1.000), and pneumonia (7.3% vs. 10.4%, P = 0.761), despite more frequent use of overlap anastomosis in the NT group (68.3% vs. 34.8%, P = 0.001). After a median follow-up of 21 months ( n = 129), the NT group showed superior 2-year overall survival (OS) (87.5% vs. 71.0%, P = 0.042), with pCR patients achieving 100% 2-year OS.

Conclusion:

NT significantly improves pathological responses and survival in advanced AEG without increasing surgical risks. The robotic-assisted approach enables the safe implementation of this multimodal treatment strategy.

Visual Abstract:

http://links.lww.com/MS9/B274

More from our Archive